← Leaderboards
Warren Kline Bolton
University Of Virginia Charlottesville
$2,625,219
Attributed
$2,625,219
Total exposure
9
Grants
5
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $604K · FY2005–11$1M$750K$500K$250K$0
'05
'06
'07
'08
'09
'10
'11
Funding mix
By agency
NIH$2,625,219 · 9
By mechanism
R01$1,665,819 · 2
M01$547,320 · 6
R21$412,080 · 1
Top collaborators
No co-investigators on record.
Most similar at University Of Virginia Charlottesville
Same institution · by research overlap
- Robert Munson Carey$21,056,299
- Michael O Thorner$7,721,062
- Harini Bagavant$2,563,013
- Robin A Felder$10,596,071
Others in their field
Top investigators on “Clinical Research”
- David Heimbrook · Leidos Biomedical Research, Inc.$1,040,569,537
- Leonard Freedman · Leidos Biomedical Research, Inc.$975,089,882
- Lawrence Corey · Fred Hutchinson Cancer Center$739,766,552
- Sonia M Thomas · Research Triangle Institute$700,865,642
- Jeffrey P Krischer · University Of South Florida$611,867,176
- Barton F Haynes · Duke University$538,862,577
Research focus
Clinical ResearchMorbidity - Disease RateMimeticsEnd Stage Renal FailureKidneyImmuneCytokineHuman SubjectAntigensRenal FunctionDrug Screening /EvaluationPathogenesisHuman Therapy EvaluationGlomerulonephritisResourcesMalnutritionKidney DisorderFuturePathologic ProcessAmino AcidsDouble-Blind MethodDown-RegulationCholinesterase InhibitorsDisease Progression
Grant awards (19)
Experimental Autoimmune Nephritis: Epitope Spreading in Pathogenesis and Control$306,864
R01 · FY2011 · DK · contact PI
Experimental Autoimmune Nephritis: Epitope Spreading in Pathogenesis and Control$310,218
R01 · FY2010 · DK · contact PI
Experimental Autoimmune Nephritis: Epitope Spreading in Pathogenesis and Control$313,602
R01 · FY2009 · DK · contact PI
GROWTH HORMONE SECRETAGOGUE MK-677 THERAPY EFFECT ON IGF-1 LEVELS IN CKD & ESRD$45,821
M01 · FY2009 · RR · contact PI
Experimental Autoimmune Nephritis: Epitope Spreading in Pathogenesis and Control$322,717
R01 · FY2008 · DK · contact PI
Growth hormone secretagogue MK-677 therapy in CKD and ESRD$222,705
R21 · FY2008 · DK · contact PI
GROWTH HORMONE SECRETAGOGUE MK-677 THERAPY EFFECT ON IGF-1 LEVELS IN CKD & ESRD$58,600
M01 · FY2008 · RR · contact PI
Growth hormone secretagogue MK-677 therapy in CKD and ESRD$189,375
R21 · FY2007 · DK · contact PI
ASSESSMENT OF GHRELIN LEVELS IN END STAGE RENAL DISEASE (ESRD)$12,253
M01 · FY2006 · RR · contact PI
ASSESSMENT OF GHRELIN LEVELS IN CHRONIC KIDNEY DISEASE$11,030
M01 · FY2005 · RR
Assessment Of Ghrelin Levels In Chronic Kidney Disease$46,358
M01 · FY2004 · RR
DONEPEZIL HYDROCHLORIDE (ARICEPT) PHARMACOKINETICS$48,533
M01 · FY2002 · RR
NEPHRITOGENIC EPITOPES IN GOODPASTURES SYNDROME$211,285
R01 · FY2001 · DK
DONEPEZIL HYDROCHLORIDE (ARICEPT) PHARMACOKINETICS$48,533
M01 · FY2001 · RR
PLACEBO CONTROLLED SAFETY AND EFFICACY OF AMINOGUANIDINE IN DIABETIC PATIENTS$248,088
M01 · FY2000 · RR
NEPHRITOGENIC EPITOPES IN GOODPASTURES SYNDROME$201,133
R01 · FY2000 · DK
PLACEBO CONTROLLED SAFETY AND EFFICACY OF AMINOGUANIDINE IN DIABETIC PATIENTS$28,104
M01 · FY2000 · RR
DONEPEZIL HYDROCHLORIDE (ARICEPT) PHARMACOKINETICS$0
M01 · FY2000 · RR
DONEPEZIL HYDROCHLORIDE (ARICEPT) PHARMACOKINETICS$0
M01 · FY2000 · RR